CDH2 and neoplasm: These signaling events eventually increase the expression of a group of genes such as N-cadherin, vimentin and Zeb1, which trigger metastatic changes including epithelial mesenchymal transition (EMT), enhancement of motility and the invasiveness of tumor cells40.